TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
ACHIM Biotherapeutics AB
Closing information (x1000 EUR)
Closing information | 2023/06 | 2022/06 | 2021/06 |
Turnover | 79 | 96 | |
Financial expenses | 0 | 0 | |
Earnings before taxes | 9 | 34 | |
EBITDA | 9 | 34 | |
Total assets | 59 | 64 | |
Current assets | 59 | 64 | |
Current liabilities | 11 | 24 | |
Equity capital | 47 | 40 | |
- share capital | 14 | 5 | |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2023/06 | 2022/06 | 2021/06 |
Solvency | 79.7% | 62.5% | |
Turnover per employee | 79 | 96 | |
Profit as a percentage of turnover | 11.4% | 35.4% | |
Return on assets (ROA) | 15.3% | 53.1% | |
Current ratio | 536.4% | 266.7% | |
Return on equity (ROE) | 19.1% | 85.0% | |
Change turnover | -12 | 18 | |
Change turnover % | -100% | -13% | 24% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/06 | 2022/06 | 2021/06 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.